Matches in Nanopublications for { ?s ?p "[Identification of the synthetic cannabinoid R(+)WIN55,212-2 as a novel regulator of IFN regulatory factor 3 activation and IFN-beta expression: relevance to therapeutic effects in models of multiple sclerosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP476632.RAbNWxhf8Zy1W7TgiRGlL8HqnLjiTQVQ63dLkAYesmb54130_assertion description "[Identification of the synthetic cannabinoid R(+)WIN55,212-2 as a novel regulator of IFN regulatory factor 3 activation and IFN-beta expression: relevance to therapeutic effects in models of multiple sclerosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP476632.RAbNWxhf8Zy1W7TgiRGlL8HqnLjiTQVQ63dLkAYesmb54130_provenance.
- assertion description "[Identification of the synthetic cannabinoid R(+)WIN55,212-2 as a novel regulator of IFN regulatory factor 3 activation and IFN-beta expression: relevance to therapeutic effects in models of multiple sclerosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Identification of the synthetic cannabinoid R(+)WIN55,212-2 as a novel regulator of IFN regulatory factor 3 activation and IFN-beta expression: relevance to therapeutic effects in models of multiple sclerosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP866133.RAaZ1O3iSe8CyeZaQiPU6EVeARWy0AdpdMMbTE7Csxdw0130_assertion description "[Identification of the synthetic cannabinoid R(+)WIN55,212-2 as a novel regulator of IFN regulatory factor 3 activation and IFN-beta expression: relevance to therapeutic effects in models of multiple sclerosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP866133.RAaZ1O3iSe8CyeZaQiPU6EVeARWy0AdpdMMbTE7Csxdw0130_provenance.
- NP477824.RAnU5dNQObvLQ9K0OUAInWZny7DiG0ipYd0WUnb72NTfk130_assertion description "[Identification of the synthetic cannabinoid R(+)WIN55,212-2 as a novel regulator of IFN regulatory factor 3 activation and IFN-beta expression: relevance to therapeutic effects in models of multiple sclerosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP477824.RAnU5dNQObvLQ9K0OUAInWZny7DiG0ipYd0WUnb72NTfk130_provenance.
- NP866132.RAvP19LStQpuLrVmnWRgiEb2j-kmWnJn9y6YqGEwnnJjc130_assertion description "[Identification of the synthetic cannabinoid R(+)WIN55,212-2 as a novel regulator of IFN regulatory factor 3 activation and IFN-beta expression: relevance to therapeutic effects in models of multiple sclerosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP866132.RAvP19LStQpuLrVmnWRgiEb2j-kmWnJn9y6YqGEwnnJjc130_provenance.